Platelets directly enhance neutrophil transmigration in response to oxidised low-density lipoprotein

Thrombosis and Haemostasis

Volumn 108, Issue 4, 2012, Pages 719-729

  Badrnya, Sigrun ^a   Butler, Lynn M ^b   Söderberg Naucler, Cecilia ^b   Volf, Ivo ^a   Assinger, Alice ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Neutrophil recruitment; Oxidised LDL; Platelet immunology; Pselectin

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ACETYLSALICYLIC ACID; CD11B ANTIGEN; OXIDIZED LOW DENSITY LIPOPROTEIN; PADGEM PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B INHIBITOR;

ARTICLE; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INCUBATION TIME; LEUKOCYTE ACTIVATION; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE AGGREGATION; UMBILICAL VEIN ENDOTHELIAL CELL;

ANTIGENS, CD11B; ASPIRIN; ATHEROSCLEROSIS; BLOOD PLATELETS; CELL AGGREGATION; CELL COMMUNICATION; CELL MOVEMENT; CHROMONES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; LIPOPROTEINS, LDL; MORPHOLINES; NEUTROPHILS; P-SELECTIN; PHOSPHATIDYLINOSITOL 3-KINASES; PLATELET ACTIVATION; PURINERGIC P2Y RECEPTOR ANTAGONISTS; SIGNAL TRANSDUCTION;

EID: 84867239486     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH12-03-0206     Document Type: Article

References (43)

1. Lievens D, von Hundelshausen P. Platelets in atherosclerosis. Thromb Haemost 2011; 106: 827-838.
2. Wagner DD, Burger PC. Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol 2003; 23: 2131-2137.
3. Gawaz M, Langer H, May AE: Platelets in inflammation and atherogenesis. J Clin Invest 2005; 115: 3378-3384.
4. von Hundelshausen P, Weber C. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res 2007; 100: 27-40.
5. Massberg S, Brand K, Gruner S, et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 2002; 196: 887-896.
6. Totani L, Evangelista V. Platelet-leukocyte interactions in cardiovascular disease and beyond. Arterioscler Thromb Vasc Biol 2010; 30: 2357-2361.
7. Diacovo TG, Roth SJ, Buccola JM, et al. Neutrophil rolling, arrest, and trans-migration across activated, surface-adherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18. Blood 1996; 88: 146-157.
8. Larsen E, Celi A, Gilbert GE, et al. PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 1989; 59: 305-312.
9. Linden MD, Furman MI, Frelinger AL, III, et al. Indices of platelet activation and the stability of coronary artery disease. J Thromb Haemost 2007; 5: 761-765.
10. Lievens D, Zernecke A, Seijkens T, et al. Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis. Blood 2010; 116: 4317-4327.
11. Drechsler M, Megens RT, van Zandvoort M, et al. Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation 2010; 122: 1837-1845.
12. Furman MI, Barnard MR, Krueger LA, et al. Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol 2001; 38: 1002-1006.
13. Lam FW, Burns AR, Smith CW, et al. Platelets enhance neutrophil transendothelial migration via P-selectin glycoprotein ligand-1. Am J Physiol Heart Circ Physiol 2011; 300: H468-H475.
14. Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med 1999; 340: 115-126.
15. van der Wal AC, Becker AE. Atherosclerotic plaque rupture--pathologic basis of plaque stability and instability. Cardiovasc Res 1999; 41: 334-344.
16. Steinberg D, Parthasarathy S, Carew TE, et al. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915-924.
17. Avogaro P, Bittolo BG, Cazzolato G. Isolation and partial characterization of an oxidized LDL in humans. Basic Life Sci 1988; 49: 391-396.
18. Harats D, Ben-Naim M, Dabach Y, et al. Effect of vitamin C and E supplementation on susceptibility of plasma lipoproteins to peroxidation induced by acute smoking. Atherosclerosis 1990; 85: 47-54.
19. Lehr HA, Hubner C, Finckh B, et al. Role of leukotrienes in leukocyte adhesion following systemic administration of oxidatively modified human low density lipoprotein in hamsters. J Clin Invest 1991; 88: 9-14.
20. Lehr HA, Olofsson AM, Carew TE, et al. P-selectin mediates the interaction of circulating leukocytes with platelets and microvascular endothelium in response to oxidized lipoprotein in vivo. Lab Invest 1994; 71: 380-386.
21. Quinn MT, Parthasarathy S, Fong LG, et al. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci USA 1987; 84: 2995-2998.
22. Siegel-Axel D, Daub K, Seizer P, et al. Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis. Cardiovasc Res 2008; 78: 8-17.
23. Assinger A, Koller F, Schmid W, et al. Hypochlorite-oxidized LDL induces intra-platelet ROS formation and surface exposure of CD40L--a prominent role of CD36. Atherosclerosis 2010; 213: 129-134.
24. Assinger A, Laky M, Schabbauer G, et al Efficient phagocytosis of periodontopa-thogens by neutrophils requires plasma factors, platelets and TLR2. J Thromb Haemost 2011; 9: 799-809.
25. Butler LM, Jeffery HC, Wheat RL, et al. Kaposi's sarcoma-associated herpesvirus infection of endothelial cells inhibits neutrophil recruitment through an interleu-kin-6-dependent mechanism: a new paradigm for viral immune evasion. J Virol 2011; 85: 7321-7332.
26. Volf I, Roth A, Cooper J, et al. Hypochlorite modified LDL are a stronger agonist for platelets than copper oxidized LDL. FEBS Lett 2000; 483: 155-159.
27. Arnhold J, Wiegel D, Richter O, et al. Modification of low density lipoproteins by sodium hypochlorite. Biomed Biochim Acta 1991; 50: 967-973.
28. Moore JE, Jr., Xu C, Glagov S, et al. Fluid wall shear stress measurements in a model of the human abdominal aorta: oscillatory behavior and relationship to atherosclerosis. Atherosclerosis 1994; 110: 225-240.
29. Soehnlein O. Multiple roles for neutrophils in atherosclerosis. Circ Res 2012; 110: 875-888.
30. Mayadas TN, Johnson RC, Rayburn H, et al. Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell 1993; 74: 541-554.
31. Pitchford SC, Momi S, Giannini S, et al. Platelet P-selectin is required for pulmonary eosinophil and lymphocyte recruitment in a murine model of allergic inflammation. Blood 2005; 105: 2074-2081.
32. van Gils JM, Zwaginga JJ, Hordijk PL. Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardio-vascular diseases. J Leukoc Biol 2009; 85: 195-204.
33. Huo Y, Schober A, Forlow SB, et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 2003; 9: 61-67.
34. Lukasik M, Dworacki G, Michalak S, et al. Aspirin treatment influences platelet-related inflammatory biomarkers in healthy individuals but not in acute stroke patients. Thromb Res 2011; 128: e73-e80.
35. Boncler M, Gresner P, Nocun M, et al. Elevated cholesterol reduces acetylsalicylic acid-mediated platelet acetylation. Biochim Biophys Acta 2007; 1770: 1651-1659.
36. Furuno T, Yamasaki F, Yokoyama T, et al. Effects of various doses of aspirin on platelet activity and endothelial function. Heart Vessels 2011; 26: 267-273.
37. Haseruck N, Erl W, Pandey D, et al. The plaque lipid lysophosphatidic acid stimulates platelet activation and plateletmonocyte aggregate formation in whole blood: involvement of P2Y1 and P2Y12 receptors. Blood 2004; 103: 2585-2592.
38. Li N, Hu H, Hjemdahl P: Aspirin treatment does not attenuate platelet or leukocyte activation as monitored by whole blood flow cytometry. Thromb Res 2003; 111: 165-170.
39. Fierro IM, Colgan SP, Bernasconi G, et al. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells. J Immunol 2003; 170: 2688-2694.
40. Pitchford SC. Novel uses for anti-platelet agents as anti-inflammatory drugs. Br J Pharmacol 2007; 152: 987-1002.
41. Leon C, Ravanat C, Freund M, et al. Differential involvement of the P2Y1 and P2Y12 receptors in platelet procoagulant activity. Arterioscler Thromb Vasc Biol 2003; 23: 1941-1947.
42. Leon C, Alex M, Klocke A, et al. Platelet ADP receptors contribute to the initiation of intravascular coagulation. Blood 2004; 103: 594-600.
43. Nakhaei-Nejad M, Hussain AM, Zhang QX, et al. Endothelial PI 3-kinase activity regulates lymphocyte diapedesis. Am J Physiol Heart Circ Physiol 2007; 293: H3608-H3616.